Codes / ICD10CM / M1A.4491

M1A.4491 Other secondary chronic gout, unspecified hand, with tophus (tophi)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Other Secondary Chronic Gout, Unspecified Hand, with Tophus (tophi)

Summary

Other secondary chronic gout, unspecified hand, with tophus (tophi) is a form of arthritis affecting the hand joints, resulting from elevated uric acid levels due to an identifiable underlying condition or cause. It leads to recurrent joint inflammation and potential tissue damage, with symptoms that may persist over time. Advanced stages involve the formation of tophi (urate crystal deposits) in the hand area.

Causes

Other secondary chronic gout, unspecified hand, with tophus arises from an underlying condition that disrupts uric acid metabolism, causing accumulation in the blood. This can stem from overproduction of uric acid or reduced renal clearance due to factors like chronic kidney disease, certain medications, or hematologic disorders. Over time, urate crystals deposit in the hand joints and surrounding tissues, triggering inflammation and tophus formation.

Risk Factors

  • Underlying conditions that affect uric acid metabolism (e.g., certain hematologic disorders, enzyme deficiencies)
  • Medications that increase uric acid levels (e.g., some diuretics, chemotherapy agents)
  • Chronic kidney disease or renal impairment
  • History of gout or hyperuricemia
  • Exposure to substances that disrupt uric acid excretion

Symptoms

  • Recurrent episodes of intense hand joint pain, often with swelling and redness
  • Persistent warmth and tenderness in affected joints
  • Visible or palpable tophi (urate crystal deposits) in the hand area
  • Limited range of motion in affected joints
  • Chronic joint stiffness or deformity over time

Diagnosis

Diagnosis involves a combination of clinical evaluation, patient history, and laboratory tests. Joint fluid analysis may reveal urate crystals, and imaging (e.g., X-rays, ultrasound) can detect tophi or joint damage. Blood tests assess uric acid levels and rule out underlying conditions contributing to secondary gout.

Treatment Options

Treatment focuses on managing uric acid levels, reducing inflammation, and addressing underlying causes. Medications may include urate-lowering agents (e.g., allopurinol), anti-inflammatory drugs, or colchicine. In some cases, tophi may require surgical intervention for removal or drainage.

Prognosis and Follow-Up

Prognosis depends on early intervention and management of underlying conditions. Regular follow-up is essential to monitor uric acid levels, adjust treatments, and prevent complications like joint damage or tophus progression. Long-term management often involves lifestyle modifications and medication adherence.

Complications

  • Chronic joint damage or deformity
  • Persistent tophi formation
  • Increased risk of kidney stones or renal impairment
  • Recurrent gout flares
  • Reduced hand function due to pain or stiffness

Lifestyle & Prevention

  • Maintain a balanced diet low in purines (e.g., limit red meat, seafood)
  • Stay hydrated to support uric acid excretion
  • Avoid alcohol, especially beer, which can elevate uric acid
  • Manage weight through regular exercise
  • Follow prescribed medication regimens consistently

When to Seek Professional Help

Seek medical attention if you experience sudden, severe hand joint pain, swelling, or redness, or if tophi are visible or growing. Prompt evaluation is crucial to prevent long-term joint damage and manage underlying conditions effectively.

Tips for Medical Coders

Document the presence of tophi (tophi) and specify the hand as "unspecified" when the exact hand is not documented. Ensure underlying causes of secondary gout are clearly recorded, as this distinguishes it from primary gout. Verify that the code aligns with clinical documentation and coding guidelines for secondary chronic gout with tophus.

Book a walkthrough

M1A.4491 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.